331 related articles for article (PubMed ID: 10036618)
1. [Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes].
Kato M
Hokkaido Igaku Zasshi; 1998 Nov; 73(6):613-25. PubMed ID: 10036618
[TBL] [Abstract][Full Text] [Related]
2. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.
Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K
J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572
[TBL] [Abstract][Full Text] [Related]
3. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G
Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
Saukkonen T; Shojaee-Moradie F; Williams RM; Amin R; Yuen KC; Watts A; Acerini CL; Umpleby AM; Dunger DB
Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
[TBL] [Abstract][Full Text] [Related]
5. Mecasermin (recombinant human insulin-like growth factor I).
Rosenbloom AL
Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus.
Zenobi PD; Jaeggi-Groisman SE; Riesen WF; Røder ME; Froesch ER
J Clin Invest; 1992 Dec; 90(6):2234-41. PubMed ID: 1469083
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
Ranke MB
Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
[TBL] [Abstract][Full Text] [Related]
9. Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I.
Longo N; Singh R; Griffin LD; Langley SD; Parks JS; Elsas LJ
J Clin Endocrinol Metab; 1994 Sep; 79(3):799-805. PubMed ID: 8077364
[TBL] [Abstract][Full Text] [Related]
10. The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.
Douglas RG; Gluckman PD; Ball K; Breier B; Shaw JH
J Clin Invest; 1991 Aug; 88(2):614-22. PubMed ID: 1864971
[TBL] [Abstract][Full Text] [Related]
11. [Leprechaunism caused by mutations in the insulin receptor gene].
Murashita M; Tajima T; Nakae J; Fujieda K
Nihon Rinsho; 2002 Feb; 60(2):344-9. PubMed ID: 11857924
[TBL] [Abstract][Full Text] [Related]
12. Absence of hypoglycemia in response to varying doses of recombinant human insulin-like growth factor-I (rhIGF-I) in children and adolescents with low serum concentrations of IGF-I.
Guevara-Aguirre J; Guevara-Aguirre M; Rosenbloom AL
Acta Paediatr; 2006 Feb; 95(2):199-202. PubMed ID: 16449027
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of recombinant human insulin-like growth factor-I in diabetic rats.
Higaki K; Matsumoto Y; Fujimoto R; Kurosaki Y; Kimura T
Drug Metab Dispos; 1997 Nov; 25(11):1324-7. PubMed ID: 9351911
[TBL] [Abstract][Full Text] [Related]
14. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
Clemmons DR; Sleevi M; Allan G; Sommer A
J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090
[TBL] [Abstract][Full Text] [Related]
15. Recombinant IGF-I therapy in insulin-dependent diabetes mellitus.
Savage MO; Dunger DB
Diabetes Metab; 1996 Jul; 22(4):257-60. PubMed ID: 8767172
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic applications of the insulin-like growth factors.
Savage MO; Camacho-Hübner C; Dunger DB
Growth Horm IGF Res; 2004 Aug; 14(4):301-8. PubMed ID: 15231299
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.
Di Cola G; Cool MH; Accili D
J Clin Invest; 1997 May; 99(10):2538-44. PubMed ID: 9153298
[TBL] [Abstract][Full Text] [Related]
18. Identification of insulin-like growth factor binding protein-2 as a biochemical surrogate marker for the in vivo effects of recombinant human insulin-like growth factor-1 in mice.
Bhat RV; Engber TM; Zhu Y; Miller MS; Contreras PC
J Pharmacol Exp Ther; 1997 Apr; 281(1):522-30. PubMed ID: 9103540
[TBL] [Abstract][Full Text] [Related]
19. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo responses to short-term recombinant human insulin-like growth factor-1 (IGF-I) in a severely growth-retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene.
de Lacerda L; Carvalho JA; Stannard B; Werner H; Boguszewski MC; Sandrini R; Malozowski SN; Leroith D; Underwood LE
Clin Endocrinol (Oxf); 1999 Nov; 51(5):541-50. PubMed ID: 10594514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
